AllDocs -> cancers

MOLECULAR P A THOLOG Y – HAEMA T O-ONCOLOG Y 32 Understanding chronic lymphocytic leukaemia Advancing its diagnosis, prognosis and treatment Daniel Catovsky DSc(Med) FRCPath FRCP FMedSci Professor of Haematology A disease of variable guises C hronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in Western countries. Indeed, in the United Kingdom alone, there are about 2,700 new cases of CLL a year, and most occurrences are in adults, particularly those over the age of 60. CLL is a heterogeneous disease, having variable symptoms and a widely varying clinical course – thus making it difficult for clinicians to determine how it will evolve (ie its prognosis) and how best to treat. For instance, it is not unknown for some patients to be diagnosed, ...

leukaemia 1186 LEUKAEMIA AND BLOOD FOUNDATION OF NEW ZEALAND TRAVEL GRANTS The Leukaemia and Blood Foundation invites applications for grants to support travel to conferences, workshops and hospital/laboratory visits. The closing dates for applications will be: 28 February 30 June 31 October Please refer to the LBF website ( www. leukaemia .org.nz ) for a current version of this form. Applications must be forwarded by a closing date prior to the time of the intended travel. Application forms along with recommendation/comment on proposed travel by immediate supervisor and/or Department Head is to be sent to: Administration Manager Leukaemia and Blood Foundation PO Box 99 182 Newmarket AUCKLAND ...

Proceedings of the TTT2005 Academic Conference - 14 - The Effect of Arsenic Trioxide (ATO) on Human Leukaemia Cells Annie Hung-Hsin Liu Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan; Genomics Research Centre, School of Health Sciences and School of Biomolecular and Biomedical Sciences, Griffith Uiversity, Australia ABSTRACT Studies into the effects of toxins on cancer cells provide clues on how to induce apoptosis of malignant cells. Arsenic Trioxide (ATO) may be effective in inducing apoptosis in rapidly dividing cells. Arsenic compounds have been used in traditional Chinese medicine for thousands of years. Commonly known as a poison, it is also used to treat a variety of ailments from syphilis to cancer. The Food and Drug Administration (FDA) approved ATO for treatment against acute promyelocytic leukaemia (APL) in 2000 (Food and Drug Administration ...

July 1998, Vol. 27 No. 4 491 Infections in Acute Lymphoblastic Leukaemia —C Y Chong et al Infections in Acute Lymphoblastic Leukaemia C Y Chong,* MBBS, MRCP (UK) , A M Tan,** FAMS, MBBS, M Med (Paed) ,J Lou,** FAMS, M Med (Paed), FRCAP (Aust) Abstract We did a retrospective study of all acute lymphoblastic leukaemia (ALL) patients on United Kingdom ALL protocol who were admitted for febrile neutropenia. The aim of the study was to document the types of infections and aetiological agents associated with febrile neutropenia and to document the factors affecting mortality. Over the 8 1 / 2 -year period from 1986 to June 1995, there were 77 episodes in 32 children with a mean of 2.4 episodes. Morbidity due to infection was 61%; unknown causes of fever contributed 39%. Of the microbiologically ...

LEUKAEMIA MEDICAL APPENDIX DEFINITION 1. The leukaemias are a group of diseases affecting the lymphatic and reticulo- endothelial systems, including the bone marrow, resulting in over production of abnormal leucocytes, with or without an increase in these cells in the circulating blood, and infiltration of various structures. Leukaemias are neoplastic diseases and may be regarded as cancers of the haemopoietic organs. They account for 2% of all cancers and of cancer deaths world-wide and 3% of all new malignancies in the UK. NORMAL BLOOD AND BONE MARROW 2. Normal blood contains three main groups of cells: red cells, leucocytes and platelets. The cyclic process of their production, circulation, removal and renewal is not yet fully understood. In health, a balance is maintained and the numbers of these formed elements is remarkably constant. 3. All mature blood cells derive from stem ...

a report by Professor Martin J S Dyer Professor of Haemato-Oncology and Honorary Consultant Physician, Medical Research Council (MRC) Toxicology Unit, University of Leicester Risk Stratification in the Treatment of Chronic Lymphocytic Leukaemia B U S I N E S S B R I E F I N G : E U R O P E A N P H A R M A C O T H E R A P Y 2 0 0 5 1 Reference Section Martin J S Dyer is Professor of Haemato-Oncology and Honorary Consultant Physician in the Medical Research Council (MRC) Toxicology Unit at the University of Leicester. His research interests are the antibody therapy and molecular genetics of B-cell malignancy. He worked for 11 years at the Royal Marsden Hospital with Professor Daniel Catovsky, following his training in medicine at Oxford and Cambridge Universities in the UK. Introduction One of the greatest medical ...

For lack of knowledge our people are dying Dear Sir/Madam DWIB LEUKAEMIA TRUST INVITATION TO BE A PATRON OF THE TRUST The Dwib Leukaemia Trust (Ghana) has been formed with the aim to increase awareness of leukaemia in the West African sub-Region and create access to effective diagnostic and treatment resources. Most of all, it aims to set up the first bone marrow register in West Africa, possibly at the Korle- bu Teaching Hospital. We acknowledge with deep respect your singular achievements in your field of endeavour and your interest in progress and development. It is in the light of this that we feel honoured to invite you to become a patron of the organization. We believe that your credibility and respect will greatly enhance the achievements of the Trust’s noble aims and objectives. We hope that should you accept, together, we shall convert the unpleasant tragedy of leukaemia ...

95 RECENT ADVANCES IN THE THERAPY OF ACUTE LEUKAEMIA * HAU C. KWAAN, M.D., F.R.C.P. (EDIN.), F.A.C.P. From the Department of Medicine, Northwestern University Medical School, and the Haematology Section, Veterans Administration Research Hospital, Chicago, Illinois, U.S.A. In recent years, significant advances have been made in the understanding of malignant diseases; leading to significant improvements in the survival rate. Among the various neoplastic conditions the improvements in the morbidity and mortality figures in acute leukaemia show perhaps the best results. While the diagnosis of acute leukaemia carried with it grave prognostic implications as recently as ten years ago, it is possible today to speak of a "cure” with chemo- therapy. I would like to discuss the following key factors that are contributing ...

leukaemia Growth Hormone Deficiency in Adults Treated for Acute Lymphoblastic Leukaemia During Childhood A Maaz 1; EJ McGregor2; M Bradwell1; MW English1; A Griffiths1; H Jenkinson1; D Kinch2; JR Mann1; AA Toogood2 1. Department of Paediatric Oncology, Birmingham Children’s Hospital NHS Trust, Steelhouse Lane, Birmingham, B4 6NH, UK 2. Department of Endocrinology, University Hospital of Birmingham, NHS Foundation Trust, Edgbaston, Birmingham, B15 2TH, UK Introduction Increasing number of children treated for ALL are now surviving into adulthood Until 1994 protocols for treating ALL routinely included prophylactic cranial irradiation at doses that cause pituitary hormone deficiencies presenting in childhood or adult life Growth Hormone (GH) is the most sensitive ...

Acute Lymphoblastic Leukaemia (ALL) What is leukaemia ? Leukaemia is a cancer of cells in the bone marrow (the cells which develop into blood cells). Cancer is a disease of the cells in the body. There are many types of cancer which arise from different types of cell. What all cancers have in common is that the cancer cells are abnormal and do not respond to normal control mechanisms. Large numbers of cancer cells build up because they multiply 'out of control', or because they live much longer than normal cells, or both. With leukaemia , the cancerous cells in the bone marrow spill out into the bloodstream. There are several types of leukaemia . Most types arise from cells which normally develop into white blood cells. (The word leukaemia comes from a greek work which means 'white blood'.) If you develop leukaemia it is important to know exactly what type it is. This is because the outlook (prognosis) ...

l del file contenuto in http://www.supercourse.cn/SupercoursePPT/6011-7001/6301.ppt . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:g8QilRs_q0AJ:www.supercourse.cn/SupercoursePPT/6011-7001/6301.ppt+leukaemia+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=339&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: leukaemia Dr Heather O Dickinson My web page Department of Child Health University of Newcastle Audit of cancer registrations notified by National Health Service Central Register in England & Wales ...

Detecting small area similarities in the epidemiology of childhood acute lymphoblastic leukaemia and type 1 diabetes: a Bayesian approach Richard G Feltbower 1* , Samuel OM Manda 2 , Mark S Gilthorpe 2 , Roger C Parslow 1 and Patricia A McKinney 1 . 1 Paediatric Epidemiology Group and 2 Biostatistics Unit, Unit of Epidemiology and Health Services Research, University of Leeds, 30 Hyde Terrace, Leeds, LS2 9LN, UK. * Tel +44(0)113 343 4841, fax +44(0)113 343 4877, Email r.g.feltbower@leeds.ac.uk. Summary Childhood acute lymphoblastic leukemia (ALL) and type 1 diabetes have common epidemiological and etiological features including correlated international incidence and associations with infections. We tested whether their similar large-scale distributions are reflected ...

HK J Paediatr (new series) 2006; 11 :69-72 Cerebral Infarction in Childhood Acute Lymphoblastic Leukaemia Treated with Low Dose E. coli Asparaginase LM P ESQUERA -L EPATAN , GCF C HAN , C L AM , MHK H O , TL L EE , AKS C HIANG , SY H A , YL L AU Section of Pediatric Hematology and Oncology, Santo Tomas University Hospital, Manila, Philippines LM P ESQUERA -L EPATAN MD Department of Paediatrics & Adolescent Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong, China GCF C HAN MD, FHKAM(Paed), FRCPCH(UK) MHK H O ...